Xigris Related Clinical Trials
Safety and Dose Finding Study of Xigris in Hemodialysis Patients [Completed]
Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis [Completed]
Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study [Completed]
A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation [Completed]
Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated) [Completed]
The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death [Completed]
A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated) [Completed]
Follow-up Data of Patients Treated With XIGRISŪ in France [Completed]
An Open Label Study of Severe Sepsis in Adults [Completed]
Effect of Intrapulmonary Recombinant Human Activated Protein C (APC) on Coagulation and Inflammation After Lipopolysaccharide (LPS) [Completed]
Quantifying Airway Inflammation With Radiologic Tests [Completed]
Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion [Completed]
Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock [Completed]
Activated Protein C to Treat Acute Lung Injuries [Terminated]
Activated Protein C and Corticosteroids for Human Septic Shock [Completed]
Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe Sepsis [Active, not recruiting]
Disease Modification in Toxaemia of Pregnancy [Completed]
Activated Protein C in Acute Stroke Trial [Terminated]
Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock [Completed]
Predicting Complications in Women With Toxaemia [Active, not recruiting]
|